MDS 2022 | Evaluating the impact of COVID-19 on patients with movement disorders

Susanne Schneider, MD, PhD, University Hospital Munich, Munich, Germany, describes the effects of the pandemic on managing movement disorders. Whilst COVID-19 negatively affected everyone mentally and physically, patients with Parkinson’s disease were especially impacted. Motor symptoms as well as mental wellbeing worsened as a result of restricted access to medical professionals and rehabilitation. People receiving COVID-19 treatment may also have restricted treatment regimens as a result of receiving treatment for COVID-19 in addition to reduced access to hospitals during lockdown. This interview took place at the 2022 International Congress of Parkinson’s Disease and Movement Disorders in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.